Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Correction to: Cellular mechanisms responsible for cell-to-cell spreading of prions.

Vilette D, Courte J, Peyrin JM, Coudert L, Schaeffer L, Andréoletti O, Leblanc P.

Cell Mol Life Sci. 2018 Jul;75(14):2575. doi: 10.1007/s00018-018-2853-5.

PMID:
29907937
2.

Cellular mechanisms responsible for cell-to-cell spreading of prions.

Vilette D, Courte J, Peyrin JM, Coudert L, Schaeffer L, Andréoletti O, Leblanc P.

Cell Mol Life Sci. 2018 Jul;75(14):2557-2574. doi: 10.1007/s00018-018-2823-y. Epub 2018 May 14. Review. Erratum in: Cell Mol Life Sci. 2018 Jul;75(14):2575.

PMID:
29761205
3.

Expression of Heterologous PrP and Prion Propagation in RK13 Cells.

Arellano-Anaya ZE, Huor A, Leblanc P, Andréoletti O, Vilette D.

Methods Mol Biol. 2017;1658:95-104. doi: 10.1007/978-1-4939-7244-9_8.

PMID:
28861785
4.

Isolation of Exosomes and Microvesicles from Cell Culture Systems to Study Prion Transmission.

Leblanc P, Arellano-Anaya ZE, Bernard E, Gallay L, Provansal M, Lehmann S, Schaeffer L, Raposo G, Vilette D.

Methods Mol Biol. 2017;1545:153-176.

PMID:
27943213
5.

Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification.

Moudjou M, Chapuis J, Mekrouti M, Reine F, Herzog L, Sibille P, Laude H, Vilette D, Andréoletti O, Rezaei H, Dron M, Béringue V.

Sci Rep. 2016 Jul 7;6:29116. doi: 10.1038/srep29116.

6.

Mutated but Not Deleted Ovine PrP(C) N-Terminal Polybasic Region Strongly Interferes with Prion Propagation in Transgenic Mice.

Khalifé M, Reine F, Paquet-Fifield S, Castille J, Herzog L, Vilotte M, Moudjou M, Moazami-Goudarzi K, Makhzami S, Passet B, Andréoletti O, Vilette D, Laude H, Béringue V, Vilotte JL.

J Virol. 2015 Nov 25;90(3):1638-46. doi: 10.1128/JVI.02805-15. Print 2016 Feb 1.

7.

Efficient inhibition of infectious prions multiplication and release by targeting the exosomal pathway.

Vilette D, Laulagnier K, Huor A, Alais S, Simoes S, Maryse R, Provansal M, Lehmann S, Andreoletti O, Schaeffer L, Raposo G, Leblanc P.

Cell Mol Life Sci. 2015 Nov;72(22):4409-27. doi: 10.1007/s00018-015-1945-8. Epub 2015 Jun 6.

PMID:
26047659
8.

Prion strains are differentially released through the exosomal pathway.

Arellano-Anaya ZE, Huor A, Leblanc P, Lehmann S, Provansal M, Raposo G, Andréoletti O, Vilette D.

Cell Mol Life Sci. 2015 Mar;72(6):1185-96. doi: 10.1007/s00018-014-1735-8. Epub 2014 Sep 18.

PMID:
25227242
9.

White blood cell-based detection of asymptomatic scrapie infection by ex vivo assays.

Halliez S, Jaumain E, Huor A, Douet JY, Lugan S, Cassard H, Lacroux C, Béringue V, Andréoletti O, Vilette D.

PLoS One. 2014 Aug 14;9(8):e104287. doi: 10.1371/journal.pone.0104287. eCollection 2014.

10.

Preclinical detection of variant CJD and BSE prions in blood.

Lacroux C, Comoy E, Moudjou M, Perret-Liaudet A, Lugan S, Litaise C, Simmons H, Jas-Duval C, Lantier I, Béringue V, Groschup M, Fichet G, Costes P, Streichenberger N, Lantier F, Deslys JP, Vilette D, Andréoletti O.

PLoS Pathog. 2014 Jun 12;10(6):e1004202. doi: 10.1371/journal.ppat.1004202. eCollection 2014 Jun.

11.

Highly efficient prion transmission by blood transfusion.

Andréoletti O, Litaise C, Simmons H, Corbière F, Lugan S, Costes P, Schelcher F, Vilette D, Grassi J, Lacroux C.

PLoS Pathog. 2012;8(6):e1002782. doi: 10.1371/journal.ppat.1002782. Epub 2012 Jun 21.

12.

Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models.

Lacroux C, Vilette D, Fernández-Borges N, Litaise C, Lugan S, Morel N, Corbière F, Simon S, Simmons H, Costes P, Weisbecker JL, Lantier I, Lantier F, Schelcher F, Grassi J, Castilla J, Andréoletti O.

J Virol. 2012 Feb;86(4):2056-66. doi: 10.1128/JVI.06532-11. Epub 2011 Dec 7.

13.

A simple, versatile and sensitive cell-based assay for prions from various species.

Arellano-Anaya ZE, Savistchenko J, Mathey J, Huor A, Lacroux C, Andréoletti O, Vilette D.

PLoS One. 2011;6(5):e20563. doi: 10.1371/journal.pone.0020563. Epub 2011 May 31.

14.

Mammalian prions: tracking the infectious entities.

Savistchenko J, Arellano-Anaya ZE, Andréoletti O, Vilette D.

Prion. 2011 Apr-Jun;5(2):84-7. Epub 2011 Apr 1.

15.

Recovery of small infectious PrP(res) aggregates from prion-infected cultured cells.

Anaya ZE, Savistchenko J, Massonneau V, Lacroux C, Andréoletti O, Vilette D.

J Biol Chem. 2011 Mar 11;286(10):8141-8. doi: 10.1074/jbc.M110.165233. Epub 2011 Jan 6.

16.

Infection of cell lines with experimental and natural ovine scrapie agents.

Neale MH, Mountjoy SJ, Edwards JC, Vilette D, Laude H, Windl O, Saunders GC.

J Virol. 2010 Mar;84(5):2444-52. doi: 10.1128/JVI.01855-09. Epub 2009 Dec 23.

17.

Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs.

Tribouillard-Tanvier D, Dos Reis S, Gug F, Voisset C, Béringue V, Sabate R, Kikovska E, Talarek N, Bach S, Huang C, Desban N, Saupe SJ, Supattapone S, Thuret JY, Chédin S, Vilette D, Galons H, Sanyal S, Blondel M.

PLoS One. 2008 May 14;3(5):e2174. doi: 10.1371/journal.pone.0002174.

18.

Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions.

Tribouillard-Tanvier D, Béringue V, Desban N, Gug F, Bach S, Voisset C, Galons H, Laude H, Vilette D, Blondel M.

PLoS One. 2008 Apr 23;3(4):e1981. doi: 10.1371/journal.pone.0001981.

19.

A cell line infectible by prion strains from different species.

Courageot MP, Daude N, Nonno R, Paquet S, Di Bari MA, Le Dur A, Chapuis J, Hill AF, Agrimi U, Laude H, Vilette D.

J Gen Virol. 2008 Jan;89(Pt 1):341-7.

PMID:
18089759
20.

Cell models of prion infection.

Vilette D.

Vet Res. 2008 Jul-Aug;39(4):10. Epub 2007 Nov 27. Review.

21.

PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells.

Paquet S, Daude N, Courageot MP, Chapuis J, Laude H, Vilette D.

J Virol. 2007 Oct;81(19):10786-91. Epub 2007 Jul 11.

22.

Efficient dissemination of prions through preferential transmission to nearby cells.

Paquet S, Langevin C, Chapuis J, Jackson GS, Laude H, Vilette D.

J Gen Virol. 2007 Feb;88(Pt 2):706-13.

PMID:
17251590
23.

Using budding yeast to screen for anti-prion drugs.

Tribouillard D, Bach S, Gug F, Desban N, Beringue V, Andrieu T, Dormont D, Galons H, Laude H, Vilette D, Blondel M.

Biotechnol J. 2006 Jan;1(1):58-67.

PMID:
16892225
24.

Prion proteins from susceptible and resistant sheep exhibit some distinct cell biological features.

Sabuncu E, Paquet S, Chapuis J, Moudjou M, Lai TL, Grassi J, Baron U, Laude H, Vilette D.

Biochem Biophys Res Commun. 2005 Nov 25;337(3):791-8. Epub 2005 Sep 28.

PMID:
16214113
25.

Prions and exosomes: from PrPc trafficking to PrPsc propagation.

Porto-Carreiro I, Février B, Paquet S, Vilette D, Raposo G.

Blood Cells Mol Dis. 2005 Sep-Oct;35(2):143-8. Review.

PMID:
16099696
26.

Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie.

Kocisko DA, Engel AL, Harbuck K, Arnold KM, Olsen EA, Raymond LD, Vilette D, Caughey B.

Neurosci Lett. 2005 Nov 11;388(2):106-11.

PMID:
16039063
27.

Scratch-wounding renders cultivated cells less permissive to prion infection.

Etessami R, Chaumontet C, Laude H, Vilette D.

Biochem Biophys Res Commun. 2005 Apr 29;330(1):5-10.

PMID:
15781224
28.

[Exosomes: carriers of prions?].

Février B, Laude H, Raposo G, Vilette D.

Med Sci (Paris). 2005 Feb;21(2):132-3. French. No abstract available.

29.

Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells.

Féraudet C, Morel N, Simon S, Volland H, Frobert Y, Créminon C, Vilette D, Lehmann S, Grassi J.

J Biol Chem. 2005 Mar 25;280(12):11247-58. Epub 2004 Dec 23.

30.

Exosomes: a bubble ride for prions?

Février B, Vilette D, Laude H, Raposo G.

Traffic. 2005 Jan;6(1):10-7. Review.

31.

Cells release prions in association with exosomes.

Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, Laude H, Raposo G.

Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9683-8. Epub 2004 Jun 21.

32.

Prion infection of epithelial Rov cells is a polarized event.

Paquet S, Sabuncu E, Delaunay JL, Laude H, Vilette D.

J Virol. 2004 Jul;78(13):7148-52.

33.

PrPSc binding antibodies are potent inhibitors of prion replication in cell lines.

Beringue V, Vilette D, Mallinson G, Archer F, Kaisar M, Tayebi M, Jackson GS, Clarke AR, Laude H, Collinge J, Hawke S.

J Biol Chem. 2004 Sep 17;279(38):39671-6. Epub 2004 May 7.

34.

Cultured peripheral neuroglial cells are highly permissive to sheep prion infection.

Archer F, Bachelin C, Andreoletti O, Besnard N, Perrot G, Langevin C, Le Dur A, Vilette D, Baron-Van Evercooren A, Vilotte JL, Laude H.

J Virol. 2004 Jan;78(1):482-90.

35.

Efficient and specific down-regulation of prion protein expression by RNAi.

Tilly G, Chapuis J, Vilette D, Laude H, Vilotte JL.

Biochem Biophys Res Commun. 2003 Jun 6;305(3):548-51.

PMID:
12763028
36.

PrP polymorphisms tightly control sheep prion replication in cultured cells.

Sabuncu E, Petit S, Le Dur A, Lan Lai T, Vilotte JL, Laude H, Vilette D.

J Virol. 2003 Feb;77(4):2696-700.

37.

Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery.

Rachidi W, Vilette D, Guiraud P, Arlotto M, Riondel J, Laude H, Lehmann S, Favier A.

J Biol Chem. 2003 Mar 14;278(11):9064-72. Epub 2002 Dec 23.

38.

Overexpression of PrPc triggers caspase 3 activation: potentiation by proteasome inhibitors and blockade by anti-PrP antibodies.

Paitel E, Alves da Costa C, Vilette D, Grassi J, Checler F.

J Neurochem. 2002 Dec;83(5):1208-14.

39.

[Cell culture models of transmissible spongiform encephalopathies].

Lehmann S, Béranger F, Solassol J, Ceschia A, Perrier V, De Gassart A, Vilette D, Laude H, Kellermann O, Mangé A.

C R Biol. 2002 Jan;325(1):59-65. Review. French.

PMID:
11862623
40.

New in vivo and ex vivo models for the experimental study of sheep scrapie: development and perspectives.

Laude H, Vilette D, Le Dur A, Archer F, Soulier S, Besnard N, Essalmani R, Vilotte JL.

C R Biol. 2002 Jan;325(1):49-57. Review.

PMID:
11862622
41.

Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine prp.

Vilotte JL, Soulier S, Essalmani R, Stinnakre MG, Vaiman D, Lepourry L, Da Silva JC, Besnard N, Dawson M, Buschmann A, Groschup M, Petit S, Madelaine MF, Rakatobe S, Le Dur A, Vilette D, Laude H.

J Virol. 2001 Jul;75(13):5977-84.

42.

Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein.

Vilette D, Andreoletti O, Archer F, Madelaine MF, Vilotte JL, Lehmann S, Laude H.

Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4055-9. Epub 2001 Mar 20.

43.

Establishment of astrocyte cell lines from sheep genetically susceptible to scrapie.

Vilette D, Madelaine MF, Laude H.

In Vitro Cell Dev Biol Anim. 2000 Jan;36(1):45-9.

PMID:
10691040
44.

Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.

Nishida N, Harris DA, Vilette D, Laude H, Frobert Y, Grassi J, Casanova D, Milhavet O, Lehmann S.

J Virol. 2000 Jan;74(1):320-5.

45.

Construction and characterization of a sheep BAC library of three genome equivalents.

Vaiman D, Billault A, Tabet-Aoul K, Schibler L, Vilette D, Oustry-Vaiman A, Soravito C, Cribiu EP.

Mamm Genome. 1999 Jun;10(6):585-7.

PMID:
10341090
46.
47.

Transcription-induced deletions in plasmid vectors: M13 DNA replication as a source of instability.

Vilette D, Ehrlich SD, Michel B.

Mol Gen Genet. 1996 Sep 25;252(4):398-403.

PMID:
8879240
48.

Transcription-induced deletions in Escherichia coli plasmids.

Vilette D, Ehrlich SD, Michel B.

Mol Microbiol. 1995 Aug;17(3):493-504.

PMID:
8559068
49.

Mechanisms of illegitimate recombination.

Ehrlich SD, Bierne H, d'Alençon E, Vilette D, Petranovic M, Noirot P, Michel B.

Gene. 1993 Dec 15;135(1-2):161-6. Review.

PMID:
8276254

Supplemental Content

Loading ...
Support Center